2m 2m 2m 2m 2m 2m 2m
Pfizer (PFE)
NYSE
$30.42+$0.57 (+1.91%)
Price as of Oct 22, 2026 7:59 PM EDT- $170.1BMarket Cap
- 29.22%1-Year Change
- Drug Manufacturers - GeneralIndustry
Pfizer (PFE)
$30.42+$0.57 (+1.91%)
PFE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.85 | ||
Change | -$0.26 (-0.86%) | ||
Open | $30.00 | ||
High | $30.09 | ||
Low | $29.69 | ||
Previous Close | $29.85 | ||
Volume | 28,703,683 | ||
30-Day Average Volume | 29,954,188 | ||
1-Week Change | 2.19% | ||
1-Month Change | 7.61% | ||
1-Year Change | 29.22% | ||
3-Year Change | 18.11% | ||
5-Year Change | -9.26% | ||
Fundamentals | |||
Shares Outstanding | 5.7B | ||
Total Assets | $201.1B | ||
Market Cap | $170.1B | ||
Enterprise Value | $232.4B | ||
Period: QTR TTM FY | |||
Revenue | $15.0B | ||
Net Income | -$248.0M | ||
Free Cash Flow | $302.0M | ||
EBIT | $12.0M | ||
EBITDA | $1.6B | ||
Net Working Capital | $8.7B | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | 142 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 2 | ||
P/E | -746 | ||
PEG | 7 | ||
Price/Free Cash Flow | 563 | ||
Price/Operating Cash Flow | 204 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 5.76% | ||
Trailing Annual Dividend Yield | 5.76% | ||
Ex-Dividend Date | 11/06/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield